The inhibition of T-cell-receptor-induced Fas ligand upregulation by cyclosporine and FK 506.
Nakajima
H
H
Second Department of Surgery, Kyoto Prefectural University of Medicine, Japan.
Oka
T
T
D000818:Animals; D001483:Base Sequence; D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology*; D003602:Cytotoxicity, Immunologic; D017931:DNA Primers; D053222:Fas Ligand Protein; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007700:Kinetics; D007939:Leukemia L1210; D008562:Membrane Glycoproteins / Q000096:biosynthesis*; D051379:Mice; D008969:Molecular Sequence Data; D016853:Muromonab-CD3 / Q000494:pharmacology; D011090:Polyenes / Q000494:pharmacology; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000032:analysis / Q000096:biosynthesis; D011948:Receptors, Antigen, T-Cell / Q000187:drug effects / Q000276:immunology*; D020123:Sirolimus; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D016559:Tacrolimus / Q000494:pharmacology*; D015854:Up-Regulation
D017931:DNA Primers; C505661:FASLG protein, human; D053222:Fas Ligand Protein; C505658:Fasl protein, mouse; D007166:Immunosuppressive Agents; D008562:Membrane Glycoproteins; D016853:Muromonab-CD3; D011090:Polyenes; D012333:RNA, Messenger; D011948:Receptors, Antigen, T-Cell; D016572:Cyclosporine; D020123:Sirolimus; D016559:Tacrolimus